{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:18Z","timestamp":1781089098760,"version":"3.54.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Province Medical and Health Science and Technology Project","award":["no. 2022KY877"],"award-info":[{"award-number":["no. 2022KY877"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Primary central nervous system (CNS) large B-cell lymphoma (PCNS-LBCL) is a rare and aggressive brain malignancy that is challenging to diagnose early. Conventional imaging methods, such as magnetic resonance imaging and PET-CT, may not provide conclusive results in the early stages. This case highlights the diagnostic utility of cerebrospinal fluid (CSF) IgG index, 24-hour IgG synthesis rate, and immunophenotyping, offering a reliable noninvasive approach to improve early diagnosis when imaging results are inconclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 57-year-old male presented with progressively worsening headache, altered consciousness, and cognitive impairment, which developed gradually over several weeks. These symptoms prompted further diagnostic evaluation to identify the underlying cause.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Magnetic resonance imaging revealed nonspecific abnormalities, while PET-CT showed increased metabolic activity in regions suspicious for malignancy. CSF analysis demonstrated an elevated IgG index and 24-hour IgG synthesis rate, indicating CNS immune activation. Flow cytometry revealed abnormal B-lymphocytes, confirming the diagnosis of PCNS-LBCL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient received a combined treatment regimen of R-CHOP chemotherapy and intrathecal methotrexate (MTX), chosen due to its ability to penetrate the blood\u2013brain barrier and directly target CNS lesions. This combined approach is essential for treating PCNS-LBCL and preventing further neurological damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Following treatment, the patient showed significant clinical improvement, with normalization of CSF parameters and recovery of neurological function, including improved cognitive abilities and motor skills. At the 1-year follow-up, imaging studies showed no relapse, and flow cytometry confirmed the absence of abnormal B-lymphocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case demonstrates the potential of integrating CSF IgG index, 24-hour IgG synthesis rate, and immunophenotyping as reliable, noninvasive diagnostic tools for the early detection of PCNS-LBCL, especially when imaging findings are inconclusive. The approach may offer valuable insights for improving diagnostic accuracy in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000047208","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:00:59Z","timestamp":1769191259000},"page":"e47208","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic utility of cerebrospinal fluid IgG index, 24-hour IgG synthesis rate, and immunophenotyping in primary central nervous system large B-cell lymphoma: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2268-9569","authenticated-orcid":false,"given":"Yiqi","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The First People\u2019s Hospital of Jiashan, Jiashan Hospital Affiliated to Jiaxing University, Jiaxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zhejiang Provincial People\u2019s Hospital, People\u2019s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6668-3068","authenticated-orcid":false,"given":"Jianguo","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihua","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First People\u2019s Hospital of Jiashan, Jiashan Hospital Affiliated to Jiaxing University, Jiaxing, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid Neoplasms.","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/cancers15082285","article-title":"Large B-cell lymphomas in the 5th edition of the WHO-classification of haematolymphoid neoplasms-updated classification and new concepts.","volume":"15","author":"Kurz","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.beha.2011.12.001","article-title":"Primary CNS lymphoma.","volume":"25","author":"Ferreri","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.21037\/tcr-22-2341","article-title":"Recent advances and challenges in primary central nervous system lymphoma: a narrative review.","volume":"12","author":"Ma","year":"2023","journal-title":"Transl Cancer Res"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","article-title":"Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European association for neuro-oncology.","volume":"16","author":"Hoang-Xuan","year":"2015","journal-title":"Lancet Oncol"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neurol.2020.08.004","article-title":"Cerebrospinal fluid interleukin-10 may be a useful biomarker for atypical primary central nervous system lymphoma relapse.","volume":"177","author":"Autier","year":"2021","journal-title":"Revue Neurol"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0387-7604(00)00165-0","article-title":"Lyme borreliosis mimicking central nervous system malignancy: the diagnostic pitfall of cerebrospinal fluid cytology.","volume":"22","author":"Kieslich","year":"2000","journal-title":"Brain Dev"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/neuonc\/noab020","article-title":"Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the international primary CNS lymphoma collaborative group (IPCG).","volume":"23","author":"Barajas","year":"2021","journal-title":"Neuro Oncol"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.crad.2011.03.006","article-title":"Imaging of primary central nervous system lymphoma.","volume":"66","author":"Tang","year":"2011","journal-title":"Clin Radiol"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"15","DOI":"10.21037\/aol-20-52","article-title":"Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review.","volume":"5","author":"Krebs","year":"2021","journal-title":"Ann Lymphoma"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.hoc.2016.03.005","article-title":"Neuroimaging in central nervous system lymphoma.","volume":"30","author":"Nabavizadeh","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1212\/01.wnl.0000261909.28915.83","article-title":"CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.","volume":"68","author":"Bromberg","year":"2007","journal-title":"Neurology"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-023-00439-0","article-title":"Primary central nervous system lymphoma.","volume":"9","author":"Ferreri","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jocn.2018.01.034","article-title":"Spinal primary central nervous system lymphoma: case report and literature review.","volume":"50","author":"Feng","year":"2018","journal-title":"J Clin Neurosci"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neurol.2022.06.014","article-title":"CSF biomarkers in primary CNS lymphoma.","volume":"179","author":"Nguyen-Them","year":"2023","journal-title":"Rev Neurol (Paris)"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2020008377","article-title":"Primary central nervous system lymphoma.","volume":"140","author":"Schaff","year":"2022","journal-title":"Blood"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"100213","DOI":"10.1016\/j.esmoop.2021.100213","article-title":"How we treat primary central nervous system lymphoma.","volume":"6","author":"Calimeri","year":"2021","journal-title":"ESMO Open"},{"key":"R18-20260610","first-page":"510","article-title":"[Primary central nervous system lymphoma: advances in treatment strategies].","volume":"61","author":"Kondo","year":"2020","journal-title":"Rinsho Ketsueki"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-019-1317-3","article-title":"Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Neurol"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s007010170058","article-title":"The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours \u2013 a prospective study.","volume":"143","author":"Kreth","year":"2001","journal-title":"Acta Neurochir (Wien)"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/clinchem\/hvac061","article-title":"An update on laboratory-based diagnostic biomarkers for multiple sclerosis and beyond.","volume":"68","author":"Saadeh","year":"2022","journal-title":"Clin Chem"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"120760","DOI":"10.1016\/j.jns.2023.120760","article-title":"IgG index of cerebrospinal fluid can reflect pathophysiology associated with Lewy bodies in Parkinson\u2019s disease.","volume":"452","author":"Murakami","year":"2023","journal-title":"J Neurol Sci"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/acn3.561","article-title":"Elevated LGI1-IgG CSF index predicts worse neurological outcome.","volume":"5","author":"Gadoth","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"322","DOI":"10.18632\/oncotarget.27340","article-title":"Morphological and immunophenotypic characterization of perivascular interstitial cells in human glioma: telocytes, pericytes, and mixed immunophenotypes.","volume":"11","author":"Mitrofanova","year":"2020","journal-title":"Oncotarget"},{"key":"R25-20260610","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis.","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"R26-20260610","doi-asserted-by":"crossref","first-page":"105435","DOI":"10.1016\/j.msard.2024.105435","article-title":"Consensus recommendations for diagnosis and treatment of multiple sclerosis: 2023 revision of the MENACTRIMS guidelines.","volume":"83","author":"Yamout","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"R27-20260610","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2015.06.015","article-title":"Biomarkers in multiple sclerosis.","volume":"161","author":"Housley","year":"2015","journal-title":"Clin Immunol"},{"key":"R28-20260610","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/cid\/ciad437","article-title":"State-of-the-art review: neurosyphilis.","volume":"78","author":"Hamill","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R29-20260610","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1906228","article-title":"Neurosyphilis.","volume":"381","author":"Ropper","year":"2019","journal-title":"N Engl J Med"},{"key":"R30-20260610","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"R31-20260610","doi-asserted-by":"crossref","first-page":"e16365","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review.","volume":"31","author":"Bellanti","year":"2024","journal-title":"Eur J Neurol"},{"key":"R32-20260610","first-page":"5","article-title":"[metastatic brain tumors].","volume":"73","author":"Shirahata","year":"2021","journal-title":"Brain Nerve"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:01:23Z","timestamp":1781085683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047208","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-02-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}